Skip to main content
. 2018 Dec 10;18:1534735418817833. doi: 10.1177/1534735418817833

Table 3.

Integrative Herbal Medicine: Chemotherapy-Induced Peripheral Neurotoxicity (WHO Grades III + IV).a

Chemotherapy Regimen: No. of Studies (No. of Participants); No. of Studies With 0 Events in Both Groups No. of Studies (No. of Participants) in Meta-Analysis Effect Size RR [95% CI] I2 Study ID (RCTs With 0 Events in Both Groups)
FOLFOX4: 13 (836); 6 7 (532) 0.41 [0.16, 1.04] 0% 13, 17, 29, 37, 42, 48, 60 (1, 3, 4, 12, 14, 27)
FOLFOX6: 1 (70); 1 0 (0) Both groups = 0 events (20)
mFOLFOX6: 2 (129); 1 1 (75) 0.18 [0.04, 0.75]b 50 (63)
FOLFOX: 1 (62); 0 1 (62) 0.50 [0.05, 5.23] 8
Pool for similar chemotherapyc: 17 (1097); 8 9 (669) 0.33 [0.16, 0.70]b 0% 8, 13, 17, 29, 37, 42, 48, 50, 60 (1, 3, 4, 12, 14, 20, 27, 63)
XELOX: 10 (490);74 3 (180) 0.66 [0.18, 2.47] 0% 10, 15, 45 (19, 25, 28, 51)
SOX: 2 (106); 0 2 (106) 0.67 [0.11, 3.92] 0% 6, 62
XELIRI: 2 (66); 2 0 (0) Both groups = 0 events (5, 26)
Total pool: 31 (1759); 17 14 (955) 0.42 [0.23, 0.77]b 0% All above

Abbreviations: WHO, World Health Organization; CI, confidence interval; RR, relative risk; RCT, randomized controlled trial.

a

All studies used oral herbal medicines combined with chemotherapy versus the same chemotherapy.

b

Statistically significant.

c

These chemotherapy regimens all used oxaliplatin, 5-fluorouracil (5-FU) plus leucovorin (LV).